Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Current Assets (2014 - 2026)

Mesoblast's (MEOBF) quarterly Current Assets came in at $197.5 million in Q2 2026, down 3.36% year-over-year from $204.4 million in Q2 2025, and down 2.47% quarter-over-quarter from $202.5 million in Q4 2025.

Analysis

Mesoblast (MEOBF) Current Assets (2014 - 2026) Analysis & Trends

Mesoblast has disclosed Current Assets across 13 years of filings, most recently posting $197.5 million for Q2 2026.

  • In Q2 2026, Current Assets fell 3.36% year-over-year to $197.5 million; the TTM figure through Jun 2026 stood at $197.5 million (down 3.36% YoY), while the FY2026 annual figure was $197.5 million, down 3.36% from the prior year.
  • Current Assets came in at $197.5 million for Q2 2026 at Mesoblast, down from $202.5 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $204.4 million in Q2 2025 to a low of $61.4 million in Q1 2023.
  • Average Current Assets over 5 years is $109.8 million, with a median of $85.8 million recorded in 2023.
  • Year-over-year, Current Assets plunged 52.89% in 2022 and soared 190.59% in 2025.
  • Over 5 years, Current Assets stood at $78.1 million in 2022, then advanced by 8.99% to $85.2 million in 2023, then dropped by 18.17% to $69.7 million in 2024, then surged by 190.59% to $202.5 million in 2025, then slipped by 2.47% to $197.5 million in 2026.
  • Per Business Quant data, the three most recent Current Assets figures were $197.5 million in Q2 2026, $202.5 million in Q4 2025, and $204.4 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 1.06 Bn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - 2.37 Bn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 464.26 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 1.23 Bn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 834.27 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - 1.18 Bn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 134.38 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn 2.22 Bn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 264.73 Mn
10 Mesoblast 246.02 Mn 143.11 Mn - 197.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 197.49 Mn
Dec 31, 2025 202.48 Mn
Jun 30, 2025 204.35 Mn
Dec 31, 2024 69.68 Mn
Jun 30, 2024 86.46 Mn
Dec 31, 2023 85.15 Mn
Jun 30, 2023 81.66 Mn
Mar 31, 2023 61.37 Mn
Dec 31, 2022 78.13 Mn
Sep 30, 2022 92.96 Mn
Jun 30, 2022 69.84 Mn
Mar 31, 2022 88.13 Mn
Dec 31, 2021 108.80 Mn
Sep 30, 2021 126.22 Mn
Jun 30, 2021 148.23 Mn
Mar 31, 2021 169.77 Mn
Dec 31, 2020 90.46 Mn
Sep 30, 2020 115.74 Mn
Jun 30, 2020 136.55 Mn
Mar 31, 2020 69.39 Mn